Rialto Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Rialto Wealth Management's PFE Position: Q1 2026 in Review
Rialto Wealth Management increased its Pfizer (PFE) stake by 8.3% in Q1 2026, buying an estimated $2.58K and bringing the position to 1,266 shares worth $35.5K. The position accounts for 0.01% of the portfolio, ranked #318.
Rialto Wealth Management first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Rialto Wealth Management held 1,266 shares of Pfizer worth $35.5K as of Q1 2026.
- Rialto Wealth Management bought 97 Pfizer shares in Q1 2026, an estimated $2.58K.
- Pfizer made up 0.01% of Rialto Wealth Management's portfolio in Q1 2026, its #318 holding.
- Rialto Wealth Management first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Rialto Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.